Valiant Laboratories Statistics
Total Valuation
NSE:VALIANTLAB has a market cap or net worth of INR 4.19 billion. The enterprise value is 4.10 billion.
| Market Cap | 4.19B |
| Enterprise Value | 4.10B |
Important Dates
The last earnings date was Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:VALIANTLAB has 54.31 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 54.31M |
| Shares Outstanding | 54.31M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 24.36% |
| Owned by Institutions (%) | 3.47% |
| Float | 20.22M |
Valuation Ratios
The trailing PE ratio is 66.34.
| PE Ratio | 66.34 |
| Forward PE | n/a |
| PS Ratio | 2.25 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 59.19, with an EV/FCF ratio of -5.25.
| EV / Earnings | 80.88 |
| EV / Sales | 2.20 |
| EV / EBITDA | 59.19 |
| EV / EBIT | 85.01 |
| EV / FCF | -5.25 |
Financial Position
The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.85 |
| Quick Ratio | 1.79 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 7.76 |
| Debt / FCF | -0.69 |
| Interest Coverage | 14.89 |
Financial Efficiency
Return on equity (ROE) is 1.85% and return on invested capital (ROIC) is 0.84%.
| Return on Equity (ROE) | 1.85% |
| Return on Assets (ROA) | 0.77% |
| Return on Invested Capital (ROIC) | 0.84% |
| Return on Capital Employed (ROCE) | 1.35% |
| Revenue Per Employee | 23.55M |
| Profits Per Employee | 641,759 |
| Employee Count | 79 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 9.79 |
Taxes
In the past 12 months, NSE:VALIANTLAB has paid 2.13 million in taxes.
| Income Tax | 2.13M |
| Effective Tax Rate | 4.03% |
Stock Price Statistics
The stock price has decreased by -29.28% in the last 52 weeks. The beta is -0.31, so NSE:VALIANTLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.31 |
| 52-Week Price Change | -29.28% |
| 50-Day Moving Average | 83.78 |
| 200-Day Moving Average | 94.31 |
| Relative Strength Index (RSI) | 33.93 |
| Average Volume (20 Days) | 29,916 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:VALIANTLAB had revenue of INR 1.86 billion and earned 50.70 million in profits. Earnings per share was 1.16.
| Revenue | 1.86B |
| Gross Profit | 285.94M |
| Operating Income | 48.24M |
| Pretax Income | 52.83M |
| Net Income | 50.70M |
| EBITDA | 67.37M |
| EBIT | 48.24M |
| Earnings Per Share (EPS) | 1.16 |
Balance Sheet
The company has 629.06 million in cash and 537.69 million in debt, giving a net cash position of 91.37 million or 1.68 per share.
| Cash & Cash Equivalents | 629.06M |
| Total Debt | 537.69M |
| Net Cash | 91.37M |
| Net Cash Per Share | 1.68 |
| Equity (Book Value) | 3.17B |
| Book Value Per Share | 73.04 |
| Working Capital | 1.26B |
Cash Flow
In the last 12 months, operating cash flow was -160.18 million and capital expenditures -620.92 million, giving a free cash flow of -781.10 million.
| Operating Cash Flow | -160.18M |
| Capital Expenditures | -620.92M |
| Free Cash Flow | -781.10M |
| FCF Per Share | -14.38 |
Margins
Gross margin is 15.37%, with operating and profit margins of 2.59% and 2.73%.
| Gross Margin | 15.37% |
| Operating Margin | 2.59% |
| Pretax Margin | 2.84% |
| Profit Margin | 2.73% |
| EBITDA Margin | 3.62% |
| EBIT Margin | 2.59% |
| FCF Margin | n/a |
Dividends & Yields
NSE:VALIANTLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | 1.21% |
| FCF Yield | -18.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |